What the superinvestors bought and sold in 2025 Q3
2025 Q3
136 of 137 filedThe quarter at a glance
78 of 136 managers were net sellers. Setting price aside, they took $38.2B out, led by Information Technology (−$24.3B), while adding to Consumer Staples (+$1.8B). FISV was the most widely bought stock (11 bought, 1 sold); GOOGL / GOOG the most widely sold (35 sold, 14 bought).
Net buyers
48 of 136 managers
78 sold more than they bought · 10 about even
Net bought
−$38.2B
Price moves taken out; prices alone moved the book +$89.2B.
Positions opened
739
681 closed out. IPOs, spin-offs and mergers left out.
Combined book, last quarter
+9.1%
SPY +7.8%,
1.2 pts ahead.
Price only.
Most bought and sold
Ranked by how many managers bought minus how many sold, with price moves taken out. Open a stock to see who.
Most bought
-
1 FISV Fiserv, Inc. 11 bought · 1 sold +$1.6B
Bought by
- Claude Leveille - Courant Investment Management opened 8.7% of book
- Dodge & Cox added 2.9% → 2.7%
- Vulcan Value Partners opened 1.9% of book
- Hillman Capital Management opened 1.7% of book
- David Tepper - Appaloosa opened 1.6% of book
- Norbert Lou - Punch Card Management opened 1.5% of book
- Robert Olstein - Olstein Capital Management added 1.0% → 1.4%
- Bill Nygren / Oakmark - Harris Associates L P added 1.5% → 1.4%
and 3 more
Sold by
- Leon Cooperman - Omega Advisors closed was 2.4%
-
2 ELV Elevance Health Inc. Formerly 9 bought · 1 sold +$1.1B
Bought by
- Glenn Greenberg - Brave Warrior Advisors added 9.9% → 13.8%
- Seth Klarman - Baupost Group added 5.8% → 8.9%
- Ruane, Cunniff & Goldfarb added 7.3% → 7.8%
- Leon Cooperman - Omega Advisors added 3.8% → 3.4%
- Vulcan Value Partners added 2.2% → 2.5%
- First Eagle Investment Management added 2.4% → 2.4%
- Arnold Van Den Berg - Van Den Berg Management I added 2.0% → 2.3%
- Bill Nygren / Oakmark - Harris Associates L P added 1.4% → 1.7%
and 1 more
Sold by
- Dan Sundheim - D1 Capital Partners closed was 1.8%
-
3 AMZN Amazon.com, Inc. 21 bought · 13 sold −$106M
Bought by
- Altarock Partners added 25.1% → 30.3%
- Triple Frond Partners added 10.8% → 12.9%
- Grant Wonders - Voyager Global Management added 12.0% → 12.1%
- Eric Mandelblatt - Soroban Capital Partners added 10.3% → 11.9%
- Robert Karr - Joho Capital opened 10.3% of book
- John Armitage - Egerton Capital (UK) added 7.5% → 9.4%
- Corvex Management added 6.3% → 7.1%
- George Soros - Soros Fund Management added 1.1% → 7.0%
and 13 more
Sold by
- Valueact Capital - Valueact Holdings cut 15.2% → 13.0%
- Polen Capital Management cut 9.4% → 8.0%
- David Tepper - Appaloosa cut 9.2% → 7.4%
- Ram Parameswaran - Octahedron Capital Management cut 8.2% → 4.1%
- Stephen Mandel - Lone Pine Capital cut 7.9% → 4.5%
- Philippe Laffont - Coatue Management cut 6.2% → 4.7%
- Alex Sacerdote - Whale Rock Capital Management cut 4.8% → 3.7%
- Gavin Baker - Atreides Management cut 4.4% → 2.8%
and 5 more
-
4 MDB Mongodb Inc. 8 bought · 1 sold +$480M
Bought by
- Valueact Capital - Valueact Holdings added 2.6% → 6.2%
- Glen Kacher - Light Street Capital Management opened 3.6% of book
- Alex Sacerdote - Whale Rock Capital Management added 1.2% → 2.0%
- Lee Ainslie - Maverick Capital opened 0.57% of book
- Chase Coleman - Tiger Global Management opened 0.33% of book
- Davidson Kempner Capital Management opened 0.26% of book
- George Soros - Soros Fund Management opened 0.16% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.14% of book
Sold by
- Ram Parameswaran - Octahedron Capital Management cut 8.0% → 2.8%
-
5 UNH Unitedhealth Group, Inc. 17 bought · 10 sold −$975M
Bought by
- Estuary Capital Management added 7.0% → 7.5%
- Samantha Mclemore - Patient Capital Management added 2.7% → 5.1%
- Torray Investment Partners added 2.2% → 2.7%
- Farallon Capital Management added 2.2% → 2.7%
- Arnold Van Den Berg - Van Den Berg Management I added 1.7% → 2.2%
- Dodge & Cox added 1.5% → 1.8%
- Hillman Capital Management opened 1.6% of book
- Don Yacktman - Yacktman Asset Management added 0.54% → 0.83%
and 9 more
Sold by
- David Tepper - Appaloosa cut 11.9% → 0.95%
- Stephen Mandel - Lone Pine Capital closed was 3.8%
- David Witzke - Avidity Partners Management cut 2.0% → 1.4%
- Robert Olstein - Olstein Capital Management cut 1.5% → 1.1%
- Lee Ainslie - Maverick Capital closed was 1.1%
- George Soros - Soros Fund Management cut 0.39% → 0.23%
- Jensen Investment Management cut 0.04% → 0.02%
- Kentucky Trust Co. - Kentucky Trust cut 0.03% → 0.02%
and 2 more
-
6 SNPS Synopsys Inc. 9 bought · 3 sold +$1.7B
Bought by
- Philippe Laffont - Coatue Management opened 2.2% of book
- Brad Gerstner - Altimeter Capital Management opened 1.7% of book
- Polen Capital Management opened 1.7% of book
- Dan Sundheim - D1 Capital Partners opened 0.89% of book
- Gavin Baker - Atreides Management opened 0.37% of book
- Glenview Capital Management opened 0.23% of book
- Cathie Wood - Ark Investment Management added 0.10% → 0.15%
- Ron Baron - Bamco Inc. (Baron Capital) opened 0.03% of book
and 1 more
Sold by
- Torray Investment Partners closed was 1.3%
- Davidson Kempner Capital Management cut 0.42% → 0.25%
- Glen Kacher - Light Street Capital Management cut 0.39% → 0.29%
-
7 AMAT Applied Matls Inc. 9 bought · 3 sold +$1.5B
Bought by
- Abrams Bison - Abrams Bison Investments added 14.9% → 17.2%
- Christopher Davis - Davis Selected Advisers added 4.9% → 5.9%
- Lewis Sanders - Sanders Capital added 1.9% → 2.8%
- Harry Burn - Sound Shore Management added 2.3% → 2.7%
- Philippe Laffont - Coatue Management opened 1.7% of book
- David Katz - Matrix Asset Advisors added 0.95% → 1.4%
- Ben Hoskin - Value Aligned Research Advisors added 0.43% → 0.46%
- Thomas Gayner - Markel Group added 0.03% → 0.04%
and 1 more
Sold by
- Kentucky Trust Co. - Kentucky Trust cut 0.94% → 0.93%
- Torray Investment Partners cut 0.84% → 0.03%
- George Soros - Soros Fund Management cut 0.19% → 0.16%
-
8 DIS Disney Walt Co. 10 bought · 4 sold +$880M
Bought by
- Corvex Management opened 5.0% of book
- Andreas Halvorsen - Viking Global Investors added 2.1% → 3.1%
- Harry Burn - Sound Shore Management added 2.8% → 2.7%
- Lee Ainslie - Maverick Capital added 2.8% → 2.5%
- Farallon Capital Management added 2.6% → 2.4%
- Dan Sundheim - D1 Capital Partners opened 1.6% of book
- George Soros - Soros Fund Management opened 1.1% of book
- John Rogers - Ariel Investments added 0.24% → 0.61%
and 2 more
Sold by
- Lindsell Train cut 11.9% → 10.5%
- Valueact Capital - Valueact Holdings cut 11.3% → 8.5%
- Murray Stahl - Horizon Kinetics Asset Management cut <0.01% → <0.01%
- Thomas Russo - Gardner Russo & Quinn cut <0.01% → <0.01%
-
9 STZ Constellation Brands Inc. 6 bought · 0 sold +$51M
Bought by
- Robert Olstein - Olstein Capital Management opened 0.72% of book
- David Katz - Matrix Asset Advisors opened 0.49% of book
- Bill Nygren / Oakmark - Harris Associates L P added 0.46% → 0.44%
- Mason Hawkins - Southeastern Asset Management opened 0.03% of book
- Lee Ainslie - Maverick Capital opened 0.02% of book
- Murray Stahl - Horizon Kinetics Asset Management opened <0.01% of book
Sold by
No manager sold.
-
10 UPS United Parcel Service Inc. 9 bought · 3 sold −$48M
Bought by
- Bill Miller - Miller Value Partners opened 2.7% of book
- Murphy Pohlad - Murphy Pohlad Asset Management added 1.8% → 1.6%
- Hillman Capital Management opened 1.5% of book
- Robert Olstein - Olstein Capital Management added 1.1% → 1.2%
- Arnold Van Den Berg - Van Den Berg Management I opened 0.50% of book
- Kentucky Trust Co. - Kentucky Trust added 0.21% → 0.18%
- Tweedy, Browne Co. opened 0.06% of book
- Lee Ainslie - Maverick Capital added 0.03% → 0.05%
and 1 more
Sold by
- Gates Foundation Trust closed was 0.16%
- Mairs & Power cut 0.04% → 0.02%
- Jensen Investment Management cut 0.03% → 0.02%
Not counted as buying: 185 IPOs, spin-offs and new listings.
Most sold
-
1 GOOGL / GOOG Alphabet 14 bought · 35 sold +$653M
Sold by
- Grant Wonders - Voyager Global Management cut 19.1% → 12.5%
- Ram Parameswaran - Octahedron Capital Management cut 13.5% → 9.1%
- Seth Klarman - Baupost Group cut 11.3% → 9.4%
- Pat Dorsey - Dorsey Asset Management cut 10.5% → 9.4%
- First Pacific Advisors cut 10.3% → 13.1%
- Triple Frond Partners cut 10.2% → 14.6%
- Thomas Russo - Gardner Russo & Quinn cut 9.6% → 12.2%
- Lewis Sanders - Sanders Capital cut 8.4% → 10.1%
and 27 more
Bought by
- Andrew Steginsky - Steginsky Capital added 24.9% → 31.0%
- Lindsell Train added 8.4% → 13.3%
- David Rolfe - Wedgewood Partners added 7.6% → 9.2%
- Kahn Brothers Group added 1.3% → 6.2%
- Mala Gaonkar - Surgocap Partners opened 6.0% of book
- Philippe Laffont - Coatue Management added 0.99% → 5.6%
- Glen Kacher - Light Street Capital Management opened 5.0% of book
- Alex Sacerdote - Whale Rock Capital Management opened 3.4% of book
and 6 more
-
2 MSFT Microsoft Corp. 13 bought · 25 sold −$9.6B
Sold by
- Robert Karr - Joho Capital cut 39.0% → 37.6%
- Gates Foundation Trust cut 27.3% → 13.0%
- Triple Frond Partners cut 21.2% → 21.7%
- Chris Hohn - Tci Fund Management cut 17.2% → 16.3%
- Vulcan Value Partners cut 11.0% → 11.1%
- Terry Smith - Fundsmith cut 10.7% → 6.8%
- Mairs & Power cut 9.8% → 9.3%
- Jensen Investment Management cut 9.1% → 9.8%
and 17 more
Bought by
- Eric Mandelblatt - Soroban Capital Partners added 19.0% → 15.6%
- Grant Wonders - Voyager Global Management added 8.0% → 12.1%
- Brad Gerstner - Altimeter Capital Management added 7.6% → 7.9%
- Lee Ainslie - Maverick Capital added 5.6% → 6.5%
- Dan Loeb - Third Point added 2.6% → 6.3%
- Philippe Laffont - Coatue Management added 5.4% → 5.9%
- Wallace Weitz - Weitz Investment Management added 3.5% → 4.3%
- Farallon Capital Management added 3.8% → 4.1%
and 5 more
-
3 COF Capital One Financial Corp. 4 bought · 13 sold −$733M
Sold by
- Christopher Davis - Davis Selected Advisers cut 10.2% → 9.3%
- Glenn Greenberg - Brave Warrior Advisors cut 8.9% → 4.8%
- Clifford Sosin - Cas Investment Partners cut 7.3% → 6.3%
- John Armitage - Egerton Capital (UK) cut 5.1% → 4.7%
- Dan Loeb - Third Point cut 5.0% → 3.3%
- Stephen Mandel - Lone Pine Capital cut 4.7% → 4.0%
- Senator Investment Group cut 4.2% → 3.2%
- Harry Burn - Sound Shore Management cut 3.9% → 3.2%
and 5 more
Bought by
- Andreas Halvorsen - Viking Global Investors added 3.5% → 4.1%
- John Rogers - Ariel Investments added 0.45% → 0.47%
- Stanley Druckenmiller - Duquesne Family Office opened 0.23% of book
- Ron Baron - Bamco Inc. (Baron Capital) opened <0.01% of book
-
4 C Citigroup Inc. 0 bought · 8 sold −$3.3B
Sold by
- Greenhaven Associates cut 20.5% → 0.13%
- First Pacific Advisors cut 6.4% → 5.3%
- Harry Burn - Sound Shore Management cut 4.1% → 3.3%
- Richard Pzena - Pzena Investment Management cut 3.8% → 4.1%
- Bill Nygren / Oakmark - Harris Associates L P cut 2.2% → 2.2%
- Sarah Ketterer - Causeway Capital Management cut 1.7% → 1.3%
- Stanley Druckenmiller - Duquesne Family Office cut 1.4% → 1.3%
- Lewis Sanders - Sanders Capital cut 1.3% → 0.12%
Bought by
No manager bought.
-
5 GS The Goldman Sachs Group, Inc. 0 bought · 8 sold −$975M
Sold by
- Dodge & Cox cut 1.3% → 0.95%
- Robert Olstein - Olstein Capital Management cut 0.93% → 0.53%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.73%
- John Rogers - Ariel Investments cut 0.29% → 0.03%
- George Soros - Soros Fund Management cut 0.19% → 0.11%
- Don Yacktman - Yacktman Asset Management cut 0.08% → 0.08%
- Bill Nygren / Oakmark - Harris Associates L P cut 0.08% → 0.05%
- Greenhaven Associates cut 0.03% → 0.01%
Bought by
No manager bought.
-
6 ORCL Oracle Corp. 4 bought · 11 sold −$1.3B
Sold by
- Polen Capital Management cut 8.0% → 8.5%
- First Eagle Investment Management cut 4.8% → 4.5%
- Wallace Weitz - Weitz Investment Management cut 2.0% → 1.1%
- Sarah Ketterer - Causeway Capital Management cut 0.96% → 0.62%
- David Tepper - Appaloosa closed was 0.51%
- Bill Nygren / Oakmark - Harris Associates L P cut 0.36% → 0.36%
- Don Yacktman - Yacktman Asset Management closed was 0.31%
- Kentucky Trust Co. - Kentucky Trust cut 0.30% → 0.34%
and 3 more
Bought by
- Philippe Laffont - Coatue Management added 2.3% → 3.3%
- Corvex Management added 0.92% → 3.3%
- Davidson Kempner Capital Management opened 0.24% of book
- Mairs & Power added 0.03% → 0.05%
-
7 WFC Wells Fargo & Co. 0 bought · 7 sold −$1.2B
Sold by
- Harry Burn - Sound Shore Management cut 2.9% → 2.6%
- First Pacific Advisors cut 2.3% → 1.5%
- Dodge & Cox cut 2.3% → 1.8%
- Bill Nygren / Oakmark - Harris Associates L P cut 1.5% → 1.5%
- Robert Olstein - Olstein Capital Management cut 1.2% → 1.2%
- Don Yacktman - Yacktman Asset Management cut 0.16% → 0.15%
- Thomas Russo - Gardner Russo & Quinn cut 0.02% → <0.01%
Bought by
No manager bought.
-
8 LRCX Lam Research Corp. 0 bought · 7 sold −$170M
Sold by
- Triple Frond Partners cut 9.4% → 6.2%
- Philippe Laffont - Coatue Management cut 2.8% → 3.3%
- Ben Hoskin - Value Aligned Research Advisors cut 0.99% → 0.56%
- David Tepper - Appaloosa cut 0.60% → 0.67%
- Ram Parameswaran - Octahedron Capital Management closed was 0.59%
- Davidson Kempner Capital Management closed was 0.32%
- Ron Baron - Bamco Inc. (Baron Capital) cut <0.01% → <0.01%
Bought by
No manager bought.
-
9 BAC Bank Amer Corp. 3 bought · 9 sold −$3.4B
Sold by
- Warren Buffett - Berkshire Hathaway cut 11.1% → 11.0%
- Dan Sundheim - D1 Capital Partners cut 5.2% → 3.3%
- Andreas Halvorsen - Viking Global Investors cut 4.3% → 1.5%
- Harry Burn - Sound Shore Management cut 3.4% → 3.2%
- Bill Nygren / Oakmark - Harris Associates L P cut 2.3% → 2.2%
- Francois Rochon - Giverny Capital closed was 1.6%
- Dodge & Cox cut 0.47% → 0.43%
- Kahn Brothers Group cut 0.11% → 0.11%
and 1 more
Bought by
- Stanley Druckenmiller - Duquesne Family Office added 0.40% → 1.3%
- John Rogers - Ariel Investments added 0.26% → 0.30%
- Mairs & Power added <0.01% → 0.01%
-
10 LLY Eli Lilly & Co. 1 bought · 7 sold −$1.6B
Sold by
- Polen Capital Management cut 4.2% → 4.0%
- Chase Coleman - Tiger Global Management closed was 3.5%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.9%
- Andreas Halvorsen - Viking Global Investors closed was 0.94%
- Lee Ainslie - Maverick Capital closed was 0.69%
- Philippe Laffont - Coatue Management closed was 0.25%
- Ron Baron - Bamco Inc. (Baron Capital) cut 0.21% → 0.17%
Bought by
- Jensen Investment Management added 1.9% → 4.4%
Not counted as selling: 168 mergers and delistings.
Opened and closed
New positions started from zero, and positions sold down to zero. IPOs, spin-offs and mergers are left out.
Opened by the most managers
-
SNPS Synopsys Inc. 8 managers avg 0.89% of book · Philippe Laffont - Coatue Management, Brad Gerstner - Altimeter Capital Management and 6 more
Opened by
- Philippe Laffont - Coatue Management opened 2.2% of book
- Brad Gerstner - Altimeter Capital Management opened 1.7% of book
- Polen Capital Management opened 1.7% of book
- Dan Sundheim - D1 Capital Partners opened 0.89% of book
- Gavin Baker - Atreides Management opened 0.37% of book
- Glenview Capital Management opened 0.23% of book
- Ron Baron - Bamco Inc. (Baron Capital) opened 0.03% of book
- Christopher Davis - Davis Selected Advisers opened 0.02% of book
-
UNP Union Pac Corp. 7 managers avg 3.4% of book · Seth Klarman - Baupost Group, Corvex Management and 5 more
Opened by
- Seth Klarman - Baupost Group opened 7.4% of book
- Corvex Management opened 5.3% of book
- Lee Ainslie - Maverick Capital opened 3.5% of book
- Senator Investment Group opened 2.8% of book
- Dan Loeb - Third Point opened 2.3% of book
- Eric Mandelblatt - Soroban Capital Partners opened 1.8% of book
- Bill Nygren / Oakmark - Harris Associates L P opened 0.56% of book
-
KLAC Klarna Group PLC 7 managers avg 1.1% of book · Marc Stad - Dragoneer Investment Group, Ben Jacobs - Anomaly Capital Management and 5 more
Opened by
- Marc Stad - Dragoneer Investment Group opened 6.7% of book
- Ben Jacobs - Anomaly Capital Management opened 0.66% of book
- Cathie Wood - Ark Investment Management opened 0.10% of book
- George Soros - Soros Fund Management opened 0.08% of book
- Davidson Kempner Capital Management opened 0.08% of book
- Philippe Laffont - Coatue Management opened 0.03% of book
- Chase Coleman - Tiger Global Management opened 0.02% of book
-
UNH Unitedhealth Group, Inc. 7 managers avg 0.28% of book · Hillman Capital Management, Sarah Ketterer - Causeway Capital Management and 5 more
Opened by
- Hillman Capital Management opened 1.6% of book
- Sarah Ketterer - Causeway Capital Management opened 0.29% of book
- David Katz - Matrix Asset Advisors opened 0.02% of book
- Steven Check - Check Capital Management opened <0.01% of book
- Murray Stahl - Horizon Kinetics Asset Management opened <0.01% of book
- Ron Baron - Bamco Inc. (Baron Capital) opened <0.01% of book
- Bill Nygren / Oakmark - Harris Associates L P opened <0.01% of book
-
GOOGL / GOOG Alphabet 6 managers avg 2.9% of book · Mala Gaonkar - Surgocap Partners, Glen Kacher - Light Street Capital Management and 4 more
Opened by
- Mala Gaonkar - Surgocap Partners opened 6.0% of book
- Glen Kacher - Light Street Capital Management opened 5.0% of book
- Alex Sacerdote - Whale Rock Capital Management opened 3.4% of book
- Warren Buffett - Berkshire Hathaway opened 1.6% of book
- Brad Gerstner - Altimeter Capital Management opened 1.0% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.61% of book
-
FISV Fiserv, Inc. 6 managers avg 2.6% of book · Claude Leveille - Courant Investment Management, Vulcan Value Partners and 4 more
Opened by
- Claude Leveille - Courant Investment Management opened 8.7% of book
- Vulcan Value Partners opened 1.9% of book
- Hillman Capital Management opened 1.7% of book
- David Tepper - Appaloosa opened 1.6% of book
- Norbert Lou - Punch Card Management opened 1.5% of book
- Murphy Pohlad - Murphy Pohlad Asset Management opened 0.31% of book
-
MDB Mongodb Inc. 6 managers avg 0.84% of book · Glen Kacher - Light Street Capital Management, Lee Ainslie - Maverick Capital and 4 more
Opened by
- Glen Kacher - Light Street Capital Management opened 3.6% of book
- Lee Ainslie - Maverick Capital opened 0.57% of book
- Chase Coleman - Tiger Global Management opened 0.33% of book
- Davidson Kempner Capital Management opened 0.26% of book
- George Soros - Soros Fund Management opened 0.16% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.14% of book
-
AVGO Broadcom Inc. 5 managers avg 4.1% of book · Mala Gaonkar - Surgocap Partners, Polen Capital Management and 3 more
Opened by
- Mala Gaonkar - Surgocap Partners opened 6.4% of book
- Polen Capital Management opened 4.8% of book
- Stephen Mandel - Lone Pine Capital opened 3.7% of book
- Brad Gerstner - Altimeter Capital Management opened 3.2% of book
- Dan Sundheim - D1 Capital Partners opened 2.5% of book
-
MELI Mercadolibre Inc. 5 managers avg 1.9% of book · Marc Stad - Dragoneer Investment Group, Dan Sundheim - D1 Capital Partners and 3 more
Opened by
- Marc Stad - Dragoneer Investment Group opened 5.3% of book
- Dan Sundheim - D1 Capital Partners opened 3.5% of book
- Wallace Weitz - Weitz Investment Management opened 0.47% of book
- Davidson Kempner Capital Management opened 0.29% of book
- Dodge & Cox opened <0.01% of book
-
BABA Alibaba Group Holding, Ltd. 5 managers avg 1.5% of book · Glen Kacher - Light Street Capital Management, Brad Gerstner - Altimeter Capital Management and 3 more
Opened by
- Glen Kacher - Light Street Capital Management opened 3.2% of book
- Brad Gerstner - Altimeter Capital Management opened 2.3% of book
- Ben Jacobs - Anomaly Capital Management opened 1.7% of book
- Cathie Wood - Ark Investment Management opened 0.22% of book
- Polen Capital Management opened <0.01% of book
Closed out by the most managers
-
INTU Intuit 5 managers was avg 2.7% of book · Mala Gaonkar - Surgocap Partners, Stephen Mandel - Lone Pine Capital and 3 more
Closed by
- Mala Gaonkar - Surgocap Partners closed was 8.0%
- Stephen Mandel - Lone Pine Capital closed was 4.3%
- Alex Sacerdote - Whale Rock Capital Management closed was 0.95%
- Thomas Gayner - Markel Group closed was 0.02%
- Bill Nygren / Oakmark - Harris Associates L P closed was <0.01%
-
LLY Eli Lilly & Co. 5 managers was avg 1.5% of book · Chase Coleman - Tiger Global Management, Stanley Druckenmiller - Duquesne Family Office and 3 more
Closed by
- Chase Coleman - Tiger Global Management closed was 3.5%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.9%
- Andreas Halvorsen - Viking Global Investors closed was 0.94%
- Lee Ainslie - Maverick Capital closed was 0.69%
- Philippe Laffont - Coatue Management closed was 0.25%
-
AVGO Broadcom Inc. 4 managers was avg 4.5% of book · Situational Awareness, Senator Investment Group and 2 more
Closed by
- Situational Awareness closed was 15.5%
- Senator Investment Group closed was 1.6%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.58%
- Davidson Kempner Capital Management closed was 0.34%
-
LBRDA Liberty Broadband Corp. 4 managers was avg 1.2% of book · Seth Klarman - Baupost Group, George Soros - Soros Fund Management and 2 more
Closed by
- Seth Klarman - Baupost Group closed was 1.8%
- George Soros - Soros Fund Management closed was 1.8%
- Paul Singer - Elliott Investment Management closed was 1.3%
- Lee Ainslie - Maverick Capital closed was 0.01%
-
SU Suncor Energy Inc. New 4 managers was avg 1.2% of book · Lyrical Asset Management, Steven Check - Check Capital Management and 2 more
Closed by
- Lyrical Asset Management closed was 3.4%
- Steven Check - Check Capital Management closed was 1.1%
- Lewis Sanders - Sanders Capital closed was 0.20%
- Lee Ainslie - Maverick Capital closed was <0.01%
-
SPY Spdr S&P 500 ETF Tr 3 managers was avg 5.5% of book · Farallon Capital Management, Chris James - Meritage Group and 1 more
Closed by
- Farallon Capital Management closed was 14.7%
- Chris James - Meritage Group closed was 1.8%
- Cathie Wood - Ark Investment Management closed was <0.01%
-
FLUT Flutter Entmt PLC 3 managers was avg 5.0% of book · Marc Stad - Dragoneer Investment Group, Ben Jacobs - Anomaly Capital Management and 1 more
Closed by
- Marc Stad - Dragoneer Investment Group closed was 9.8%
- Ben Jacobs - Anomaly Capital Management closed was 3.3%
- Andreas Halvorsen - Viking Global Investors closed was 1.9%
-
BLDR Builders Firstsource Inc. 3 managers was avg 2.5% of book · Alex Roepers - Atlantic Investment Management, John Armitage - Egerton Capital (UK) and 1 more
Closed by
- Alex Roepers - Atlantic Investment Management closed was 7.1%
- John Armitage - Egerton Capital (UK) closed was 0.31%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.24%
-
UNH Unitedhealth Group, Inc. 3 managers was avg 1.6% of book · Stephen Mandel - Lone Pine Capital, Lee Ainslie - Maverick Capital and 1 more
Closed by
- Stephen Mandel - Lone Pine Capital closed was 3.8%
- Lee Ainslie - Maverick Capital closed was 1.1%
- Glenn Greenberg - Brave Warrior Advisors closed was 0.01%
-
AMZN Amazon.com, Inc. 3 managers was avg 1.5% of book · Andreas Halvorsen - Viking Global Investors, Dan Sundheim - D1 Capital Partners and 1 more
Closed by
- Andreas Halvorsen - Viking Global Investors closed was 2.5%
- Dan Sundheim - D1 Capital Partners closed was 2.1%
- Francois Rochon - Giverny Capital closed was <0.01%
Where the money went
Net bought by sector, with price moves taken out. Pick a sector to see its names.
- Consumer Staples 3.4% weight · −0.2 pts +$1.8B 25 bought · 15 sold
- Energy 4.2% weight · no change +$921M 17 bought · 15 sold
- Materials 3.7% weight · +0.5 pts +$565M 18 bought · 17 sold
- Consumer Discretionary 15.7% weight · +0.4 pts −$358M 45 bought · 40 sold
- Real Estate 3.3% weight · no change −$619M 10 bought · 16 sold
- Utilities 1.6% weight · −0.2 pts −$1.5B 9 bought · 14 sold
- Industrials 9.8% weight · −0.3 pts −$1.8B 33 bought · 46 sold
- Health Care 12.6% weight · +0.4 pts −$2B 43 bought · 24 sold
- Financials 17.1% weight · −0.7 pts −$3.5B 32 bought · 58 sold
- Communication Services 8.8% weight · −0.1 pts −$4.1B 25 bought · 51 sold
- Information Technology 19.8% weight · +0.3 pts −$24.3B 40 bought · 58 sold
Health Care gained weight (+0.4 pts) even though managers sold $2B of it: weight follows price, not buying. Names without a sector (funds, foreign listings, private shares): −$2.8B.
Who moved the most
The biggest new positions, measured against each manager’s own book, and the managers that traded the most of theirs.
Biggest new bets
- Mohnish Pabrai - Dalal Street opened RIG · Transocean Ltd 22.6% of book
- Situational Awareness opened CRWV · Coreweave Inc. 13.6% of book
- Alex Roepers - Atlantic Investment Management opened AXTA · Axalta Coating Sys Ltd 12.6% of book
- Robert Karr - Joho Capital opened AMZN · Amazon.com, Inc. 10.3% of book
- Mala Gaonkar - Surgocap Partners opened TSM · Taiwan Semiconductor Mfg Ltd 10.0% of book
- Sachem Head Capital Management opened PFGC · Performance Food Group Co. 9.8% of book
Most active managers
- Nehal Chopra - Ratan Capital Management 3 opened · 6 closed · −$88M net 91% of book traded
- David Witzke - Avidity Partners Management 11 opened · 21 closed · −$149M net 91% of book traded
- Glen Kacher - Light Street Capital Management 7 opened · 6 closed · +$39M net 85% of book traded
- Situational Awareness 13 opened · 2 closed · +$649M net 83% of book traded
- Sachem Head Capital Management 5 opened · 5 closed · +$6M net 76% of book traded
- Alex Roepers - Atlantic Investment Management 4 opened · 5 closed · −$62M net 75% of book traded
What they hold
Most owned counts managers, with the change since last quarter. Largest is the share of the combined book, each manager counting once. Highest conviction is the average position among holders, three or more.
Most owned
- 1 GOOGL / GOOG Alphabet 70 managers +3
- 2 MSFT Microsoft Corp. 63 managers no change
- 3 AMZN Amazon.com, Inc. 53 managers no change
- 4 META Meta Platforms Inc. 52 managers +2
- 5 TSM Taiwan Semiconductor Mfg Ltd 43 managers +4
- 6 NVDA Nvidia Corporation 37 managers +2
- 7 BRK.B / BRK.A Berkshire Hathaway 35 managers −1
- 8 V Visa Inc. 35 managers +1
- 9 DIS Disney Walt Co. 32 managers +4
- 10 UNH Unitedhealth Group, Inc. 32 managers +4
Largest
- 1 GOOGL / GOOG Alphabet 3.0% held by 70
- 2 MSFT Microsoft Corp. 2.6% held by 63
- 3 BRK.B / BRK.A Berkshire Hathaway 2.4% held by 35
- 4 AMZN Amazon.com, Inc. 2.2% held by 53
- 5 META Meta Platforms Inc. 1.6% held by 52
- 6 CVNA Carvana Co. 1.4% held by 15
- 7 TSM Taiwan Semiconductor Mfg Ltd 1.1% held by 43
- 8 NVDA Nvidia Corporation 1.0% held by 37
- 9 AAPL Apple Inc. 0.97% held by 31
- 10 V Visa Inc. 0.96% held by 35
Highest conviction
- 1 HHH Howard Hughes Holdings Inc. avg 20.4% held by 5
- 2 CVNA Carvana Co. avg 13.1% held by 15
- 3 SNX Td Synnex Corporation avg 11.7% held by 5
- 4 EQH Equitable Hldgs Inc. avg 11.5% held by 3
- 5 MDGL Madrigal Pharmaceuticals Inc. avg 9.8% held by 3
- 6 BRK.B / BRK.A Berkshire Hathaway avg 9.1% held by 35
- 7 IBKR Interactive Brokers Group In avg 8.7% held by 6
- 8 TDG Transdigm Group Inc. avg 8.3% held by 7
- 9 RIG Transocean Ltd avg 7.6% held by 3
- 10 VFC Vf Corp. avg 7.6% held by 3
Did the combined book beat SPY?
Each quarter’s combined book held to the next quarter-end, at the 13Fs’ own prices. Price only, no dividends, and today’s managers throughout. Nobody could have copied it: 13Fs arrive about 45 days after the quarter ends.
Combined book, 8 quarters
+44.2%
SPY
+37.2%
Difference
+6.9 pts
2024 Q2, the start
+0.0% Combined book
+0.0% SPY
2024 Q3, since 2024 Q2
+7.5% Combined book
+5.4% SPY
That quarter: book +7.5%, SPY +5.4%
2024 Q4, since 2024 Q2
+10.2% Combined book
+7.7% SPY
That quarter: book +2.6%, SPY +2.1%
2025 Q1, since 2024 Q2
+6.0% Combined book
+2.8% SPY
That quarter: book −3.8%, SPY −4.6%
2025 Q2, since 2024 Q2
+18.3% Combined book
+13.5% SPY
That quarter: book +11.6%, SPY +10.5%
2025 Q3, since 2024 Q2
+29.0% Combined book
+22.4% SPY
That quarter: book +9.1%, SPY +7.8%
2025 Q4, since 2024 Q2
+31.8% Combined book
+25.3% SPY
That quarter: book +2.1%, SPY +2.4%
2026 Q1, since 2024 Q2
+25.9% Combined book
+19.5% SPY
That quarter: book −4.4%, SPY −4.6%
2026 Q2, since 2024 Q2
+44.2% Combined book
+37.2% SPY
That quarter: book +14.5%, SPY +14.8%
Quarter by quarter
| Quarter | Each manager once | By dollars | SPY | Book − SPY | Managers |
|---|---|---|---|---|---|
| 2026 Q2 | +14.5% | +11.5% | +14.8% | −0.4 pts | 133 |
| 2026 Q1 | −4.4% | −4.2% | −4.6% | +0.2 pts | 136 |
| 2025 Q4 | +2.1% | +2.6% | +2.4% | −0.2 pts | 136 |
| 2025 Q3 | +9.1% | +6.3% | +7.8% | +1.2 pts | 136 |
| 2025 Q2 | +11.6% | +8.0% | +10.5% | +1.1 pts | 136 |
| 2025 Q1 | −3.8% | −2.0% | −4.6% | +0.7 pts | 136 |
| 2024 Q4 | +2.6% | +1.1% | +2.1% | +0.4 pts | 134 |
| 2024 Q3 | +7.5% | +6.9% | +5.4% | +2.1 pts | 133 |
All 2,507 names
Download CSVShowing 300 of 374 matching names. The CSV has every name.
| Ticker | Company | Sector | Held by | Weight | Net bought | Bought / sold | Opened / closed |
|---|---|---|---|---|---|---|---|
| UNH | Unitedhealth Group, Inc. | Health Care | 32 +4 | 0.37% | −$975M | 17 / 10 | 7 / 3 |
| TMO | Thermo Fisher Scientific Inc. | Health Care | 21 +2 | 0.22% | −$922M | 7 / 8 | 4 / 2 |
| DHR | Danaher Corporation | Health Care | 20 | 0.25% | −$53M | 6 / 8 | 1 / 1 |
| JNJ | Johnson & Johnson | Health Care | 16 | 0.12% | −$92M | 2 / 6 | 1 / 1 |
| CVS | Cvs Health Corp. | Health Care | 15 +1 | 0.38% | −$116M | 3 / 5 | 1 / 0 |
| ELV | Elevance Health Inc. Formerly | Health Care | 14 | 0.34% | +$1.1B | 9 / 1 | 1 / 1 |
| ABBV | Abbvie Inc. | Health Care | 13 +2 | 0.05% | +$9M | 3 / 2 | 2 / 0 |
| CI | The Cigna Group | Health Care | 12 +2 | 0.13% | +$120M | 5 / 2 | 2 / 0 |
| PFE | Pfizer Inc. | Health Care | 12 | 0.11% | −$199M | 4 / 5 | 1 / 1 |
| MRK | Merck & Co. Inc. | Health Care | 12 | 0.09% | +$64M | 2 / 4 | 0 / 0 |
| MDT | Medtronic PLC | Health Care | 11 +1 | 0.12% | −$274M | 1 / 3 | 1 / 0 |
| ZBH | Zimmer Biomet Holdings, Inc. | Health Care | 11 | 0.09% | +$220M | 3 / 4 | 0 / 0 |
| BMY | Bristol-Myers Squibb Co. | Health Care | 11 | 0.08% | −$45M | 3 / 4 | 1 / 1 |
| ABT | Abbott Labs | Health Care | 11 −1 | 0.07% | −$473M | 0 / 3 | 0 / 1 |
| TEVA | Teva Pharmaceutical Inds Ltd | Health Care | 10 +1 | 0.20% | −$63M | 4 / 2 | 1 / 0 |
| WST | West Pharmaceutical Svsc Inc. | Health Care | 10 +1 | 0.12% | +$50M | 4 / 2 | 2 / 1 |
| ICLR | Icon PLC | Health Care | 10 | 0.10% | +$30M | 4 / 5 | 3 / 3 |
| LLY | Eli Lilly & Co. | Health Care | 10 −5 | 0.09% | −$1.6B | 1 / 7 | 0 / 5 |
| GEHC | Ge Healthcare Technologies, Inc. | Health Care | 10 | 0.05% | +$311M | 4 / 2 | 0 / 0 |
| BSX | Boston Scientific Corp. | Health Care | 9 +1 | 0.17% | +$992M | 4 / 3 | 1 / 0 |
| NTRA | Natera Inc. | Health Care | 9 +1 | 0.16% | −$97M | 2 / 5 | 1 / 0 |
| HCA | Hca Healthcare Inc. | Health Care | 9 | 0.15% | −$538M | 2 / 4 | 0 / 0 |
| ZTS | Zoetis Inc. | Health Care | 9 −2 | 0.10% | −$256M | 1 / 5 | 0 / 2 |
| BAX | Baxter International, Inc. | Health Care | 9 | 0.09% | +$610M | 6 / 4 | 2 / 2 |
| BDX | Becton Dickinson & Co. | Health Care | 8 | 0.11% | +$110M | 3 / 3 | 1 / 1 |
| GSK | Gsk PLC | Health Care | 8 | 0.10% | −$31M | 2 / 4 | 0 / 0 |
| IQV | Iqvia Hldgs Inc. | Health Care | 8 | 0.08% | −$531M | 2 / 3 | 0 / 0 |
| AMGN | Amgen Inc. | Health Care | 8 | 0.05% | −$1M | 0 / 2 | 0 / 0 |
| ILMN | Illumina Inc. | Health Care | 7 −1 | 0.15% | −$9M | 3 / 4 | 2 / 3 |
| IDXX | Idexx Labs Inc. | Health Care | 7 +1 | 0.12% | −$163M | 1 / 4 | 1 / 0 |
| REGN | Regeneron Pharmaceuticals, Inc. | Health Care | 7 +1 | 0.07% | +$464M | 3 / 1 | 1 / 0 |
| TECH | Bio-Techne Corp. | Health Care | 7 +2 | 0.07% | +$325M | 4 / 2 | 3 / 1 |
| CAH | Cardinal Health Inc. | Health Care | 7 −1 | 0.04% | −$44M | 0 / 4 | 0 / 1 |
| DGX | Quest Diagnostics Inc. | Health Care | 7 +1 | 0.02% | +$4M | 1 / 2 | 1 / 0 |
| NVS | Novartis AG | Health Care | 7 | 0.02% | −$8M | 1 / 2 | 1 / 1 |
| ACHC | Acadia Healthcare Co. Inc. | Health Care | 6 +1 | 0.21% | +$123M | 5 / 0 | 1 / 0 |
| OSCR | Oscar Health Inc. | Health Care | 6 | 0.19% | +$29M | 3 / 3 | 2 / 2 |
| SOLV | Solventum Corporation | Health Care | 6 +1 | 0.19% | +$48M | 2 / 0 | 1 / 0 |
| INSM | Insmed Inc. | Health Care | 6 | 0.17% | −$57M | 1 / 3 | 0 / 0 |
| THC | Tenet Healthcare Corp. | Health Care | 6 −1 | 0.16% | −$179M | 1 / 6 | 1 / 2 |
| MCK | Mckesson Corp. | Health Care | 6 | 0.14% | +$169M | 2 / 2 | 0 / 0 |
| SYK | Stryker Corporation | Health Care | 6 −1 | 0.11% | −$105M | 0 / 2 | 0 / 1 |
| BIIB | Biogen Inc. | Health Care | 6 +1 | 0.09% | +$19M | 3 / 2 | 1 / 0 |
| VEEV | Veeva Sys Inc. | Health Care | 6 | 0.06% | +$187M | 2 / 3 | 0 / 0 |
| ALKS | Alkermes PLC | Health Care | 6 | 0.05% | −$7M | 2 / 3 | 1 / 1 |
| HUM | Humana, Inc. | Health Care | 6 +1 | 0.05% | −$314M | 2 / 2 | 2 / 1 |
| ALNY | Alnylam Pharmaceuticals, Inc. | Health Care | 6 +3 | 0.02% | −$415M | 3 / 3 | 3 / 0 |
| NVO | Novo-Nordisk A S | Health Care | 6 −2 | 0.01% | −$55M | 1 / 2 | 0 / 2 |
| IONS | Ionis Pharmaceuticals Inc. | Health Care | 5 +2 | 0.12% | −$15M | 2 / 1 | 2 / 0 |
| UHS | Universal Hlth Svcs Inc. | Health Care | 5 +1 | 0.12% | +$308M | 3 / 1 | 1 / 0 |
| AVTR | Avantor, Inc. | Health Care | 5 +2 | 0.07% | +$348M | 4 / 0 | 2 / 0 |
| SNY | Sanofi SA | Health Care | 5 −1 | 0.07% | −$133M | 3 / 1 | 0 / 1 |
| MEDP | Medpace Holdings Inc. | Health Care | 5 | 0.05% | −$50M | 0 / 3 | 0 / 0 |
| VRTX | Vertex Pharmaceuticals | Health Care | 5 | 0.05% | +$15M | 3 / 0 | 0 / 0 |
| NVST | Envista Holdings Corporation | Health Care | 5 +1 | 0.04% | −$24M | 1 / 1 | 1 / 0 |
| CNC | Centene Corp. Del | Health Care | 5 | 0.03% | −$345M | 4 / 2 | 1 / 1 |
| BNTX | Biontech Se | Health Care | 5 | 0.03% | +$273M | 2 / 1 | 0 / 0 |
| EW | Edwards Lifesciences Corp. | Health Care | 5 +1 | 0.03% | +$239M | 1 / 1 | 1 / 0 |
| BEAM | Beam Therapeutics Inc. | Health Care | 5 +2 | 0.02% | +$48M | 3 / 1 | 2 / 0 |
| ASND | Ascendis Pharma A/S | Health Care | 5 +2 | 0.02% | −$4M | 2 / 1 | 2 / 0 |
| BLCO | Bausch Plus Lomb Corp. | Health Care | 5 +2 | 0.02% | +$28M | 3 / 0 | 2 / 0 |
| EHC | Encompass Health Corp. | Health Care | 5 +1 | 0.02% | −$1M | 1 / 3 | 1 / 0 |
| BMRN | Biomarin Pharmaceutical, Inc. | Health Care | 4 +1 | 0.14% | −$220M | 1 / 2 | 1 / 0 |
| COO | Cooper Cos Inc. | Health Care | 4 +1 | 0.12% | +$175M | 2 / 2 | 2 / 1 |
| RPRX | Royalty Pharma PLC | Health Care | 4 | 0.11% | −$4M | 1 / 1 | 1 / 1 |
| WGS | Genedx Holdings Corp. | Health Care | 4 +1 | 0.08% | +$12M | 1 / 2 | 1 / 0 |
| BIO | Bio Rad Labs Inc. | Health Care | 4 | 0.06% | −$22M | 0 / 1 | 0 / 0 |
| VTRS | Viatris Inc. | Health Care | 4 −1 | 0.06% | +$29M | 0 / 1 | 0 / 1 |
| A | Agilent Technologies Inc. | Health Care | 4 | 0.05% | −$4M | 0 / 0 | 0 / 0 |
| LH | Labcorp Holdings Inc. | Health Care | 4 +1 | 0.03% | +$1M | 1 / 1 | 1 / 0 |
| HSIC | Henry Schein, Inc. | Health Care | 4 −1 | 0.02% | −$99M | 1 / 1 | 0 / 1 |
| PTGX | Protagonist Therapeutics Inc. | Health Care | 4 +1 | 0.02% | +$12M | 2 / 0 | 1 / 0 |
| COR | Cencora Inc. | Health Care | 4 | 0.02% | −$99M | 0 / 2 | 0 / 0 |
| ROIV | Roivant Sciences Ltd | Health Care | 4 +1 | 0.02% | −$194M | 1 / 2 | 1 / 0 |
| GILD | Gilead Sciences, Inc. | Health Care | 4 | 0.02% | −$92M | 1 / 2 | 0 / 0 |
| ALGN | Align Technology Inc. | Health Care | 4 −1 | 0.01% | +$789K | 1 / 1 | 0 / 1 |
| CDNA | Caredx Inc. | Health Care | 4 +1 | <0.01% | +$17M | 3 / 0 | 1 / 0 |
| ISRG | Intuitive Surgical Inc. | Health Care | 4 −2 | <0.01% | −$21M | 1 / 2 | 0 / 2 |
| DOCS | Doximity Inc. | Health Care | 4 | <0.01% | +$24M | 3 / 1 | 1 / 1 |
| BTI | British Amern Tob PLC | Health Care | 4 +1 | <0.01% | +$7M | 2 / 1 | 1 / 0 |
| RDNT | Radnet Inc. | Health Care | 4 +1 | <0.01% | +$19M | 3 / 0 | 1 / 0 |
| URGN | Urogen Pharma Ltd | Health Care | 4 +1 | <0.01% | −$7M | 1 / 2 | 1 / 0 |
| MDGL | Madrigal Pharmaceuticals Inc. | Health Care | 3 | 0.22% | −$91M | 1 / 2 | 1 / 1 |
| NVAX | Novavax Inc. | Health Care | 3 | 0.14% | +$9M | 2 / 0 | 0 / 0 |
| CGON | Cg Oncology Inc. | Health Care | 3 | 0.13% | +$10M | 2 / 0 | 0 / 0 |
| BHC | Bausch Health Cos Inc. | Health Care | 3 | 0.11% | +$22M | 2 / 1 | 1 / 1 |
| EXEL | Exelixis Inc. | Health Care | 3 | 0.09% | +$144M | 2 / 1 | 0 / 0 |
| RVMD | Revolution Medicines Inc. | Health Care | 3 −1 | 0.08% | +$2M | 0 / 1 | 0 / 1 |
| SGRY | Surgery Partners Inc. | Health Care | 3 | 0.07% | +$67M | 2 / 1 | 0 / 0 |
| ALC | Alcon AG | Health Care | 3 | 0.07% | −$1M | 1 / 1 | 0 / 0 |
| WAT | Waters Corp. | Health Care | 3 −1 | 0.07% | +$106M | 1 / 1 | 0 / 1 |
| TFX | Teleflex Incorporated | Health Care | 3 +2 | 0.07% | +$120M | 3 / 0 | 2 / 0 |
| MTD | Mettler Toledo International | Health Care | 3 −1 | 0.03% | −$33M | 1 / 2 | 0 / 1 |
| HOLX | Hologic, Inc. | Health Care | 3 −1 | 0.03% | −$6M | 0 / 1 | 0 / 1 |
| CRSP | Crispr Therapeutics AG | Health Care | 3 | 0.03% | −$26M | 0 / 1 | 0 / 0 |
| INDV | Indivior PLC | Health Care | 3 +1 | 0.03% | +$17M | 2 / 1 | 1 / 0 |
| BBIO | Bridgebio Pharma Inc. | Health Care | 3 −1 | 0.03% | −$126M | 0 / 2 | 0 / 1 |
| SNDX | Syndax Pharmaceuticals Inc. | Health Care | 3 −1 | 0.03% | +$272K | 1 / 2 | 0 / 1 |
| STOK | Stoke Therapeutics Inc. | Health Care | 3 | 0.03% | −$5M | 1 / 2 | 0 / 0 |
| XENE | Xenon Pharmaceuticals Inc. | Health Care | 3 | 0.02% | −$3M | 0 / 2 | 0 / 0 |
| NBIX | Neurocrine Biosciences, Inc. | Health Care | 3 | 0.02% | −$760K | 1 / 0 | 0 / 0 |
| AXGN | Axogen Inc. | Health Care | 3 | 0.02% | +$4M | 1 / 1 | 0 / 0 |
| ORKA | Oruka Therapeutics Inc. | Health Care | 3 +2 | 0.02% | +$58M | 3 / 0 | 2 / 0 |
| INCY | Incyte Corp. | Health Care | 3 | 0.02% | −$81M | 0 / 1 | 0 / 0 |
| CRL | Charles Riv Labs Intl Inc. | Health Care | 3 | 0.02% | +$59M | 2 / 1 | 0 / 0 |
| Perrigo | Perrigo Company PLC | Health Care | 3 +1 | 0.02% | +$9M | 2 / 0 | 1 / 0 |
| HIMS | Hims & Hers Health Inc. | Health Care | 3 +1 | 0.02% | +$156M | 2 / 1 | 1 / 0 |
| NAMS | Newamsterdam Pharma Company | Health Care | 3 | 0.02% | +$16M | 1 / 1 | 0 / 0 |
| ADPT | Adaptive Biotechnologies Cor | Health Care | 3 | 0.01% | −$11M | 1 / 1 | 0 / 0 |
| Masimo | Masimo Corp. | Health Care | 3 | <0.01% | −$34M | 1 / 1 | 0 / 0 |
| VCYT | Veracyte Inc. | Health Care | 3 +1 | <0.01% | +$15M | 2 / 1 | 1 / 0 |
| NUVB | Nuvation Bio Inc. | Health Care | 3 | <0.01% | +$917K | 1 / 0 | 0 / 0 |
| MIRM | Mirum Pharmaceuticals Inc. | Health Care | 3 +1 | <0.01% | +$61K | 1 / 1 | 1 / 0 |
| CAI | Caris Life Sciences Inc. | Health Care | 3 −1 | <0.01% | +$5M | 2 / 1 | 0 / 1 |
| HQY | Healthequity Inc. | Health Care | 3 −2 | <0.01% | −$60M | 0 / 4 | 0 / 2 |
| SDGR | Schrodinger Inc. | Health Care | 3 | <0.01% | −$18M | 0 / 1 | 0 / 0 |
| SRTA | Strata Critical Medical Inc. | Health Care | 3 +1 | <0.01% | +$16M | 2 / 1 | 1 / 0 |
| EMBC | Embecta Corp. | Health Care | 3 | <0.01% | −$2M | 1 / 1 | 0 / 0 |
| BCYC | Bicycle Therapeutics Plc-Adr | Health Care | 3 | <0.01% | −$211K | 0 / 1 | 0 / 0 |
| INSP | Inspire Med Sys Inc. | Health Care | 3 | <0.01% | −$196M | 1 / 2 | 1 / 1 |
| GRAL | Grail Inc. | Health Care | 3 | <0.01% | +$50M | 1 / 1 | 0 / 0 |
| GH | Guardant Health Inc. | Health Care | 3 | <0.01% | −$126M | 1 / 1 | 0 / 0 |
| PGNY | Progyny Inc. | Health Care | 3 −1 | <0.01% | −$1M | 1 / 1 | 0 / 1 |
| UTHR | United Therapeutics Corp. | Health Care | 2 −1 | 0.16% | −$18M | 0 / 3 | 0 / 1 |
| JAZZ | Jazz Pharmaceuticals PLC | Health Care | 2 | 0.13% | −$9M | 0 / 1 | 0 / 0 |
| ENTA | Enanta Pharmaceuticals Inc. | Health Care | 2 | 0.08% | $0 | 0 / 0 | 0 / 0 |
| ACAD | Acadia Pharmaceuticals Inc. | Health Care | 2 +1 | 0.08% | +$1M | 1 / 1 | 1 / 0 |
| LQDA | Liquidia Corporation | Health Care | 2 | 0.07% | +$102M | 2 / 0 | 0 / 0 |
| SUPN | Supernus Pharmaceuticals Inc. | Health Care | 2 | 0.07% | −$5M | 0 / 1 | 0 / 0 |
| FOLD | Amicus Therapeutics Inc. | Health Care | 2 | 0.06% | −$2M | 0 / 1 | 0 / 0 |
| ENOV | Enovis Corporation | Health Care | 2 | 0.05% | −$4M | 1 / 1 | 0 / 0 |
| CYTK | Cytokinetics Inc. | Health Care | 2 +1 | 0.04% | +$1M | 1 / 0 | 1 / 0 |
| QDEL | Quidelortho Corp. IPO or spin-off | Health Care | 2 +2 | 0.04% | +$31M | 2 / 0 | 2 / 0 |
| IRON | Disc Medicine Inc. | Health Care | 2 | 0.03% | +$6M | 1 / 0 | 0 / 0 |
| SHC | Sotera Health Co. | Health Care | 2 −1 | 0.03% | −$25M | 0 / 2 | 0 / 1 |
| IOVA | Iovance Biotherapeutics Inc. | Health Care | 2 | 0.02% | +$9M | 1 / 0 | 0 / 0 |
| DYN | Dyne Therapeutics Inc. | Health Care | 2 | 0.02% | +$13M | 1 / 0 | 0 / 0 |
| AGIO | Agios Pharmaceuticals Inc. | Health Care | 2 | 0.02% | +$414K | 0 / 0 | 0 / 0 |
| PBH | Prestige Consmr Healthcare I | Health Care | 2 | 0.02% | +$87M | 2 / 0 | 0 / 0 |
| ARVN | Arvinas Inc. | Health Care | 2 | 0.02% | −$2M | 1 / 1 | 0 / 0 |
| VNDA | Vanda Pharmaceuticals Inc. | Health Care | 2 | 0.02% | +$781K | 1 / 0 | 0 / 0 |
| LRMR | Larimar Therapeutics Inc. | Health Care | 2 | 0.02% | +$1M | 1 / 1 | 0 / 0 |
| OPCH | Option Care Health Inc. | Health Care | 2 | 0.02% | −$13M | 1 / 1 | 0 / 0 |
| RARE | Ultragenyx Pharmaceutical In | Health Care | 2 −1 | 0.02% | −$22M | 1 / 2 | 0 / 1 |
| RMD | Resmed Inc. | Health Care | 2 +1 | 0.01% | +$64M | 1 / 0 | 1 / 0 |
| EWTX | Edgewise Therapeutics Inc. | Health Care | 2 | 0.01% | −$234K | 0 / 1 | 0 / 0 |
| MMSI | Merit Med Sys Inc. | Health Care | 2 | 0.01% | +$19M | 1 / 0 | 0 / 0 |
| LKFT | Galapagos NV | Health Care | 2 | 0.01% | $0 | 0 / 0 | 0 / 0 |
| DNLI | Denali Therapeutics Inc. | Health Care | 2 | 0.01% | +$2M | 1 / 0 | 0 / 0 |
| WVE | Wave Life Sciences Ltd | Health Care | 2 +1 | <0.01% | +$3M | 1 / 0 | 1 / 0 |
| FMS | Fresenius Medical Care AG | Health Care | 2 −1 | <0.01% | +$4M | 0 / 1 | 0 / 1 |
| CMPS | Compass Pathways PLC | Health Care | 2 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| DXCM | Dexcom Inc. | Health Care | 2 −1 | <0.01% | −$18M | 0 / 2 | 0 / 1 |
| ELVN | Enliven Therapeutics Inc. | Health Care | 2 | <0.01% | +$13M | 2 / 0 | 0 / 0 |
| TWST | Twist Bioscience Corp. | Health Care | 2 | <0.01% | +$9M | 1 / 0 | 0 / 0 |
| MLYS | Mineralys Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$53M | 1 / 1 | 1 / 0 |
| MBX | Mbx Biosciences Inc. | Health Care | 2 +1 | <0.01% | +$2M | 2 / 0 | 1 / 0 |
| NKTR | Nektar Therapeutics | Health Care | 2 +1 | <0.01% | +$48M | 2 / 0 | 1 / 0 |
| ARQT | Arcutis Biotherapeutics Inc. | Health Care | 2 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| ELAN | Elanco Animal Health, Inc. | Health Care | 2 +1 | <0.01% | −$2M | 1 / 0 | 1 / 0 |
| PRQR | Proqr Therapeutics N V | Health Care | 2 +1 | <0.01% | +$402K | 1 / 0 | 1 / 0 |
| RGEN | Repligen Corp. | Health Care | 2 −1 | <0.01% | +$3M | 1 / 2 | 0 / 1 |
| IMVT | Immunovant Inc. | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| PHG | Koninklijke Philips NV | Health Care | 2 | <0.01% | +$3M | 2 / 0 | 0 / 0 |
| LXEO | Lexeo Therapeutics Inc. | Health Care | 2 | <0.01% | −$133K | 0 / 1 | 0 / 0 |
| TRVI | Trevi Therapeutics Inc. | Health Care | 2 | <0.01% | +$33M | 1 / 0 | 0 / 0 |
| PODD | Insulet Corp. | Health Care | 2 | <0.01% | −$935K | 0 / 1 | 0 / 0 |
| ORIC | Oric Pharmaceuticals Inc. | Health Care | 2 | <0.01% | −$367K | 0 / 1 | 0 / 0 |
| ADCT | Adc Therapeutics SA | Health Care | 2 +1 | <0.01% | +$3M | 1 / 0 | 1 / 0 |
| AVAH | Aveanna Healthcare Hldgs Inc. | Health Care | 2 | <0.01% | −$29M | 0 / 1 | 0 / 0 |
| BFLY | Butterfly Network Inc. | Health Care | 2 −1 | <0.01% | −$783K | 0 / 1 | 0 / 1 |
| TVTX | Travere Therapeutics Inc. | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ITGR | Integer Hldgs Corp. | Health Care | 2 | <0.01% | +$9M | 1 / 1 | 0 / 0 |
| VKTX | Viking Therapeutics Inc. | Health Care | 2 −1 | <0.01% | −$14M | 0 / 1 | 0 / 1 |
| ALLO | Allogene Therapeutics Inc. | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BCRX | Biocryst Pharmaceuticals Inc. | Health Care | 2 +1 | <0.01% | +$182K | 1 / 0 | 1 / 0 |
| SPRY | Ars Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$12M | 2 / 1 | 1 / 1 |
| HALO | Halozyme Therapeutics | Health Care | 2 +1 | <0.01% | +$160K | 1 / 0 | 1 / 0 |
| COGT | Cogent Biosciences Inc. | Health Care | 2 +1 | <0.01% | +$15M | 1 / 0 | 1 / 0 |
| BBNX | Beta Bionics Inc. | Health Care | 2 | <0.01% | +$6M | 1 / 1 | 1 / 1 |
| XRAY | Dentsply Sirona Inc. | Health Care | 2 | <0.01% | +$20K | 1 / 0 | 0 / 0 |
| WAY | Waystar Hldg Corp. | Health Care | 2 | <0.01% | +$5M | 1 / 0 | 0 / 0 |
| AXSM | Axsome Therapeutics | Health Care | 2 −2 | <0.01% | −$12M | 0 / 2 | 0 / 2 |
| PRME | Prime Medicine Inc. | Health Care | 2 | <0.01% | +$40M | 2 / 0 | 0 / 0 |
| KRYS | Krystal Biotech | Health Care | 2 | <0.01% | +$58K | 0 / 0 | 0 / 0 |
| ABVX | Abivax SA IPO or spin-off | Health Care | 2 +2 | <0.01% | +$70M | 2 / 0 | 2 / 0 |
| TMDX | Transmedics Group Inc. | Health Care | 2 | <0.01% | +$4M | 1 / 1 | 0 / 0 |
| SION | Sionna Therapeutics Inc. | Health Care | 2 | <0.01% | +$420K | 1 / 0 | 0 / 0 |
| ALVO | Alvotech SA | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| DNA | Ginkgo Bioworks Holdings Inc. | Health Care | 2 −1 | <0.01% | −$7M | 0 / 1 | 0 / 1 |
| ESTA | Establishment Labs Hldgs Inc. | Health Care | 2 | <0.01% | +$11M | 1 / 0 | 0 / 0 |
| HTFL | Heartflow Inc. IPO or spin-off | Health Care | 2 +2 | <0.01% | +$44M | 2 / 0 | 2 / 0 |
| Compugen | Compugen Ltd | Health Care | 2 −1 | <0.01% | −$2M | 0 / 1 | 0 / 1 |
| PEPG | Pepgen Inc. | Health Care | 2 | <0.01% | +$8M | 1 / 1 | 0 / 0 |
| GRFS | Grifols S A | Health Care | 2 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| MRVI | Maravai Lifesciences Hldgs I | Health Care | 2 +1 | <0.01% | +$2M | 2 / 0 | 1 / 0 |
| BKD | Brookdale Sr Living Inc. | Health Care | 2 −1 | <0.01% | −$66K | 1 / 1 | 0 / 1 |
| ATEC | Alphatec Hldgs Inc. | Health Care | 2 | <0.01% | +$105K | 1 / 0 | 0 / 0 |
| CYH | Community Health Sys Inc. New | Health Care | 2 +1 | <0.01% | +$482K | 1 / 0 | 1 / 0 |
| SRRK | Scholar Rock Hldg Corp. | Health Care | 2 +1 | <0.01% | +$673K | 1 / 0 | 1 / 0 |
| DNTH | Dianthus Therapeutics Inc. | Health Care | 1 | 0.21% | +$58M | 1 / 0 | 0 / 0 |
| HROW | Harrow Health Inc. | Health Care | 1 | 0.20% | $0 | 0 / 0 | 0 / 0 |
| STXS | Stereotaxis Inc. | Health Care | 1 | 0.08% | $0 | 0 / 0 | 0 / 0 |
| ETON | Eton Pharmaceuticals Inc. | Health Care | 1 | 0.06% | $0 | 0 / 0 | 0 / 0 |
| OGN | Organon & Co. | Health Care | 1 −1 | 0.05% | −$5M | 1 / 1 | 0 / 1 |
| RYTM | Rhythm Pharmaceuticals Inc. | Health Care | 1 | 0.05% | −$1M | 0 / 0 | 0 / 0 |
| Bausch Lomb | Bausch Lomb Corp. | Health Care | 1 | 0.04% | $0 | 0 / 0 | 0 / 0 |
| SNWV | Sanuwave Health Inc. | Health Care | 1 | 0.04% | $0 | 0 / 0 | 0 / 0 |
| ATRC | Atricure Inc. | Health Care | 1 | 0.04% | $0 | 0 / 0 | 0 / 0 |
| LFCR | Lifecore Biomedical Inc. | Health Care | 1 | 0.03% | $0 | 0 / 0 | 0 / 0 |
| ANAB | Anaptysbio Inc. | Health Care | 1 | 0.03% | −$4M | 0 / 1 | 0 / 0 |
| ADMA | Adma Biologics Inc. | Health Care | 1 | 0.03% | +$131M | 1 / 1 | 1 / 1 |
| IDYA | Ideaya Biosciences Inc. | Health Care | 1 | 0.03% | −$2M | 0 / 1 | 0 / 0 |
| PGEN | Precigen Inc. | Health Care | 1 | 0.03% | +$34M | 1 / 0 | 0 / 0 |
| NVCR | Novocure Ltd | Health Care | 1 | 0.02% | +$4M | 1 / 0 | 0 / 0 |
| TGTX | Tg Therapeutics Inc. | Health Care | 1 −1 | 0.02% | −$533K | 0 / 1 | 0 / 1 |
| OCUL | Ocular Therapeutix Inc. | Health Care | 1 | 0.02% | $0 | 0 / 0 | 0 / 0 |
| PRTA | Prothena Corp. PLC | Health Care | 1 | 0.02% | +$481K | 0 / 0 | 0 / 0 |
| CATX | Perspective Therapeutics Inc. | Health Care | 1 | 0.02% | +$4M | 1 / 0 | 0 / 0 |
| JBIO | Jade Biosciences Inc. | Health Care | 1 | 0.02% | $0 | 0 / 0 | 0 / 0 |
| PRVA | Privia Health Group Inc. | Health Care | 1 | 0.02% | +$5M | 0 / 0 | 0 / 0 |
| RCUS | Arcus Biosciences Inc. | Health Care | 1 | 0.02% | $0 | 0 / 0 | 0 / 0 |
| APGE | Apogee Therapeutics Inc. | Health Care | 1 | 0.02% | +$12M | 1 / 1 | 1 / 1 |
| CNTX | Context Therapeutics Inc. | Health Care | 1 | 0.01% | +$1M | 1 / 0 | 0 / 0 |
| GMAB | Genmab A/S | Health Care | 1 | 0.01% | −$12M | 0 / 1 | 0 / 0 |
| DVA | Davita Inc. | Health Care | 1 −1 | 0.01% | −$218M | 0 / 1 | 0 / 1 |
| XOMA | Xoma Corp. Del | Health Care | 1 | 0.01% | $0 | 0 / 0 | 0 / 0 |
| COLL | Collegium Pharmaceutical Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| Kalvista Pharmaceutic… | Kalvista Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| FTRE | Fortrea Hldgs Inc. | Health Care | 1 −1 | <0.01% | −$21M | 0 / 1 | 0 / 1 |
| BCAX | Bicara Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| INGN | Inogen Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| RZLT | Rezolute Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ANNX | Annexon Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$8M | 1 / 0 | 1 / 0 |
| TNDM | Tandem Diabetes Care Inc. | Health Care | 1 | <0.01% | +$741K | 1 / 0 | 0 / 0 |
| KURA | Kura Oncology Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| CRNX | Crinetics Pharmaceuticals In | Health Care | 1 | <0.01% | +$47M | 1 / 0 | 0 / 0 |
| CARL | Carlsmed Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| DERM | Journey Medical Corp. | Health Care | 1 | <0.01% | +$6M | 1 / 0 | 0 / 0 |
| RXRX | Recursion Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$3M | 0 / 0 | 0 / 0 |
| LZAGY | Lonza Group Adr | Health Care | 1 | <0.01% | −$229K | 0 / 0 | 0 / 0 |
| BHVN | Biohaven Ltd | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| SLGL | Sol Gel Technologies IPO or spin-off | Health Care | 1 +1 | <0.01% | +$6M | 1 / 0 | 1 / 0 |
| Enhabit | Enhabit Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| MOH | Molina Healthcare Inc. | Health Care | 1 −2 | <0.01% | +$65M | 1 / 2 | 0 / 2 |
| PHAT | Phathom Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$9M | 0 / 1 | 0 / 0 |
| CMPX | Compass Therapeutics Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| PLX | Protalix Biotherapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$6M | 1 / 0 | 1 / 0 |
| TSHA | Taysha Gene Therapies Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| MYGN | Myriad Genetics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| LNTH | Lantheus Hldgs Inc. | Health Care | 1 −1 | <0.01% | −$167M | 0 / 2 | 0 / 1 |
| AQST | Aquestive Therapeutics Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| PCVX | Vaxcyte Inc. | Health Care | 1 | <0.01% | −$758K | 0 / 0 | 0 / 0 |
| ALEC | Alector Inc. | Health Care | 1 | <0.01% | −$339K | 0 / 1 | 0 / 0 |
| ACRS | Aclaris Therapeutics Inc. | Health Care | 1 | <0.01% | +$336K | 1 / 0 | 0 / 0 |
| DMAC | Diamedica Therapeutics Inc. | Health Care | 1 | <0.01% | +$9M | 1 / 0 | 0 / 0 |
| RAPP | Rapport Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| TELA | Tela Bio Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ARAY | Accuray Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| CNTA | Centessa Pharmaceuticals PLC | Health Care | 1 | <0.01% | −$5M | 0 / 0 | 0 / 0 |
| PYXS | Pyxis Oncology Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| GPCR | Structure Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| IART | Integra Lifesciences Hldgs | Health Care | 1 | <0.01% | +$57K | 0 / 0 | 0 / 0 |
| ALMS | Alumis Inc. | Health Care | 1 −1 | <0.01% | −$1M | 0 / 2 | 0 / 1 |
| TNGX | Tango Therapeutics Inc. | Health Care | 1 | <0.01% | +$13M | 1 / 0 | 0 / 0 |
| COYA | Coya Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| RCKT | Rocket Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$341K | 0 / 0 | 0 / 0 |
| Catalyst Pharmaceutic… | Catalyst Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$13M | 1 / 0 | 0 / 0 |
| ARGX | Argenx Se | Health Care | 1 | <0.01% | −$10M | 0 / 1 | 0 / 0 |
| PSNL | Personalis Inc. | Health Care | 1 | <0.01% | +$5M | 1 / 0 | 0 / 0 |
| BDTX | Black Diamond Therapeutics I | Health Care | 1 | <0.01% | −$621K | 0 / 1 | 0 / 0 |
| IVVD | Invivyd Inc. | Health Care | 1 | <0.01% | +$10M | 1 / 0 | 0 / 0 |
| SNN | Smith & Nephew PLC | Health Care | 1 | <0.01% | −$9M | 0 / 1 | 0 / 0 |
| CABA | Cabaletta Bio Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| EOLS | Evolus Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$614K | 1 / 0 | 1 / 0 |
| IRD | Opus Genetics Inc. | Health Care | 1 | <0.01% | −$198K | 0 / 1 | 0 / 0 |
| AVBP | Arrivent Biopharma Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| PHVS | Pharvaris N V | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BRKR | Bruker Corp. | Health Care | 1 | <0.01% | +$10M | 1 / 1 | 1 / 1 |
| OBIO | Orchestra Biomed Holdings Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$902K | 1 / 0 | 1 / 0 |
| ABSI | Absci Corp. | Health Care | 1 | <0.01% | +$6M | 1 / 0 | 0 / 0 |
| ALDX | Aldeyra Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BWAY | Brainsway Ltd | Health Care | 1 −1 | <0.01% | −$4M | 0 / 2 | 0 / 1 |
| IPSC | Century Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ARCT | Arcturus Therapeutics Holdings | Health Care | 1 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| KPTI | Karyopharm Therapeutics Inc. | Health Care | 1 −1 | <0.01% | −$1M | 0 / 1 | 0 / 1 |
| ERAS | Erasca Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| CERS | Cerus Corp. | Health Care | 1 | <0.01% | −$568K | 0 / 0 | 0 / 0 |
| CELC | Celcuity Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$445K | 1 / 0 | 1 / 0 |
| CLDX | Celldex Therapeutics Inc. New IPO or spin-off | Health Care | 1 +1 | <0.01% | +$634K | 1 / 0 | 1 / 0 |
| INBX | Inhibrx Biosciences Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| SYRE | Spyre Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$1M | 1 / 0 | 1 / 0 |
| FHTX | Foghorn Therapeutics Inc. | Health Care | 1 | <0.01% | −$849K | 0 / 1 | 0 / 0 |
| RIGL | Rigel Pharmaceuticals IPO or spin-off | Health Care | 1 +1 | <0.01% | +$1M | 1 / 0 | 1 / 0 |
| QURE | Uniqure NV | Health Care | 1 −1 | <0.01% | +$20M | 1 / 1 | 0 / 1 |
| NGNE | Neurogene Inc. | Health Care | 1 | <0.01% | −$359K | 0 / 1 | 0 / 0 |
| ASMB | Assembly Biosciences Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$31M | 1 / 0 | 1 / 0 |
| ZLAB | Zai Lab Ltd | Health Care | 1 | <0.01% | −$7M | 0 / 1 | 0 / 0 |
| OSUR | Orasure Technologies Inc. | Health Care | 1 | <0.01% | +$26K | 1 / 0 | 0 / 0 |
| USNA | Usana Health Sciences Inc. | Health Care | 1 | <0.01% | +$395K | 0 / 0 | 0 / 0 |
How the numbers work
Same managers in both quarters
Changes compare only managers with a 13F in both 2025 Q2 and 2025 Q3: 136 this time.
Buying versus price
Each holding’s dollar change splits into price (what last quarter’s shares earned by this quarter’s 13F price) and net bought (shares added or cut, times this quarter’s price), using each 13F’s own values. The two add back to the change exactly. Stock splits are adjusted first.
Who counts as a buyer or a seller
A manager bought a stock if it opened a position, or added at least 5% to its shares or a trade worth 0.25% of its book; it sold if it closed the position or cut it by the same amounts. Smaller changes count as holding, and a stock split never counts. A manager was a net buyer for the quarter when its trading added up to at least 0.25% of its book. GOOG and GOOGL count once.
IPOs, spin-offs and mergers
A stock no tracked manager held last quarter (an IPO, a spin-off, a new share class) is not counted as buying, and one nobody holds now (a merger, a delisting) is not counted as selling. Choose them under All names to see them.
Each manager once, or by dollars
By default every manager counts the same, so a list leads with what the most managers did. By dollars ranks by money moved and weighs holdings by size, so the largest books set the order.
Sectors
GICS sectors where the company has one. Funds, foreign listings and private shares have none; their buying is shown on its own, never filed under Other. Sector weights are shares of the names that have a sector.
The combined book against SPY
Each quarter-end’s combined book is held to the next quarter-end at the 13Fs’ own prices: price only, no dividends, and today’s featured managers for every quarter. SPY is the same filings’ price for SPY. It is a record of what the managers held, not something anyone could have copied, because 13Fs arrive about 45 days after the quarter ends.
What a 13F leaves out
Long US-listed stock only: no shorts, cash, bonds or foreign listings, and options are left out here.